Menu Back to DIA-Singapore-2019


Organized by DIA and CoRE

Scientific breakthroughs, growing amounts of healthcare data and globalization hold great promises for better health outcomes for patients in need.

Data analytics, real-world evidence, remote clinical monitoring, connected health records, electronic labeling and mobile health apps are among some of the trending topics that will shape the healthcare landscape in the coming years.

Alongside the advances in scientific understanding and health product development overall, paradigm shifts in regulatory processes and global convergence are important for greater synergy among all to bring forth timely innovation benefits to patients and consumers and patients that will improve health outcomes.

Who should attend?

  • Industry professionals involved in Research & Development, Regulatory Affairs and Medical Affairs in Pharmaceuticals and Medical Technology
  • Regulators and personnel from Health Authorities and Ministries
  • Academia and Researchers

Program Committee

  • Dorothee  Grimald, PharmD
    Dorothee Grimald, PharmD Director, Global Regulatory Policy
    MSD Singapore, Singapore
  • James  Leong, PhD, MPharm
    James Leong, PhD, MPharm Head of Pharmaceutical Regulatory Science Programme
    Duke NUS, Singapore
  • Finny   Liu, MSc, RPh
    Finny Liu, MSc, RPh APAC Regional Regulatory Policy Lead
    Roche Singapore Pte Ltd, Singapore
  • Mei  Ding
    Mei Ding JAPAC Regional Lead, Policy & Intelligence
    Abbvie Pte. Ltd., Singapore
  • Khairul Faizi  Khalid, MD
    Khairul Faizi Khalid, MD Head of Business Development
    Clinical Research Malaysia, Malaysia
  • Thean Soo  Lo
    Thean Soo Lo
    Regulatory Affairs Management Consultant, Singapore
  • Shun  Jin, MBA
    Shun Jin, MBA Head, Regulatory Affairs, APMA
    Sandoz Asia Pacific Pharmaceutical Pte., Ltd., Singapore
  • Jing Ping  Yeo, PhD
    Jing Ping Yeo, PhD Director, Research Integrity, Compliance and Ethics
    Singhealth, Singapore
  • Kum Cheun  Wong, PharmD
    Kum Cheun Wong, PharmD Head Asia Pacific Regulatory & Development Policy
    Novartis Asia Pacific Pharmaceuticals Pte. Ltd., Singapore
  • Lars  Nelleman, MD, MPharm
    Lars Nelleman, MD, MPharm Founder and Owner
    Lars Nelleman Consulting, Singapore
  • Vicky (Fengyun)  Han
    Vicky (Fengyun) Han Senior Director, Asia Pacific Regulatory Policy Group Lead, Asia Pacific
    Johnson & Johnson Pte. Ltd., Singapore
Load More

Contact us

Digital Learning Catalog

DIA Learning: eLearning Soultions